We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PhRMA Seeks Easing of Breakthrough Therapy Designation Criteria
PhRMA Seeks Easing of Breakthrough Therapy Designation Criteria
September 11, 2013
PhRMA is prodding the FDA to broaden the criteria it uses for designating a drug as a breakthrough therapy to allow more candidates to win breakthrough status.